APOA1 (-75 G>A and 83 C>T) and APOB (2488 C>T) polymorphisms and their association with myocardial infarction, lipids and apolipoproteins in patients with type 2 diabetes mellitus
- PMID: 36457989
- PMCID: PMC9710253
- DOI: 10.5114/aoms/108674
APOA1 (-75 G>A and 83 C>T) and APOB (2488 C>T) polymorphisms and their association with myocardial infarction, lipids and apolipoproteins in patients with type 2 diabetes mellitus
Abstract
Introduction: The increased risk of myocardial infarction (MI) in type 2 diabetes mellitus (T2DM) is well documented. Polymorphisms in APOA1 and APOB genes allow us to identify new genetic markers in the Mexican population with T2DM and MI.
Material and methods: We studied 135 patients with DMT2 and MI (DI); another 85 non-infarcted diabetic individuals with DMT2 but without previous ischemic events (NID) and 242 healthy subjects (HS). All three groups were selected with the aim to investigate the association between the polymorphisms and infarction when T2DM is present or absent.
Results: -75 G>A polymorphism: Differences were found in genotype distribution between DI and NID individuals (OR = 2.01, 95% CI: 1.117-3.623, p = 0.019) with an increased risk for A in the dominant model (OR = 1.77, 95% CI: 1.020-3.084, p = 0.042); also concentrations of ApoA-I for A/A were lower in comparison with G/A (p = 0.038) and LDL-C and HDL-C levels were lower in G/A compared to G/G carriers. 83 C>T polymorphism of APOA1: For DI individuals, HDL-C was lower in T/T compared to C/C and triglyceride levels were lower in C/T compared to C/C carriers.
Conclusions: The -75 G>A APOA1 polymorphism could be considered as a susceptibility factor for myocardial infarction in individuals with T2DM and 2488 C>T APOB polymorphism is associated with changes in HDL-C and LDL-C and triglycerides in the same group.
Keywords: apolipoproteins; lipids; myocardial infarction; type 2 diabetes mellitus.
Copyright: © 2021 Termedia & Banach.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.Nutr Metab Cardiovasc Dis. 2020 May 7;30(5):788-795. doi: 10.1016/j.numecd.2020.01.008. Epub 2020 Jan 21. Nutr Metab Cardiovasc Dis. 2020. PMID: 32127339
-
Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.Acta Med Croatica. 2001;55(4-5):161-7. Acta Med Croatica. 2001. PMID: 12398019
-
ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women.Endocrinol Diabetes Nutr (Engl Ed). 2019 Oct;66(8):502-511. doi: 10.1016/j.endinu.2019.03.019. Epub 2019 Jun 8. Endocrinol Diabetes Nutr (Engl Ed). 2019. PMID: 31182348 English, Spanish.
-
Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.Cardiovasc Diabetol. 2012 Oct 8;11:123. doi: 10.1186/1475-2840-11-123. Cardiovasc Diabetol. 2012. PMID: 23039238 Free PMC article.
-
Pitavastatin: novel effects on lipid parameters.Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Atheroscler Suppl. 2011. PMID: 22152282 Review.
Cited by
-
Low-Density Lipoprotein Receptor Apolipoprotein B Gene Polymorphism in Kurdish Patients With Severe Hypercholesterolemia.Cureus. 2024 Sep 28;16(9):e70387. doi: 10.7759/cureus.70387. eCollection 2024 Sep. Cureus. 2024. PMID: 39469407 Free PMC article.
-
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?Arch Med Sci. 2023 Nov 2;19(6):1602-1615. doi: 10.5114/aoms/174743. eCollection 2023. Arch Med Sci. 2023. PMID: 38058712 Free PMC article.
-
Anti-inflammatory mechanism of Apolipoprotein A-I.Front Immunol. 2024 Jul 8;15:1417270. doi: 10.3389/fimmu.2024.1417270. eCollection 2024. Front Immunol. 2024. PMID: 39040119 Free PMC article. Review.
References
-
- IDF diabetes atlas - Home.
-
- Mortalidad . http://www.beta.inegi.org.mx/proyectos/registros/vitales/mortalidad/. Accessed September 8, 2017.
-
- Stančáková A, Laakso M. Genetics of type 2 diabetes. Endocr Dev 2016; 31: 203-20. - PubMed
-
- DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, et al. . Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014; 46: 234-44. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous